JP2020507342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020507342A5 JP2020507342A5 JP2019564394A JP2019564394A JP2020507342A5 JP 2020507342 A5 JP2020507342 A5 JP 2020507342A5 JP 2019564394 A JP2019564394 A JP 2019564394A JP 2019564394 A JP2019564394 A JP 2019564394A JP 2020507342 A5 JP2020507342 A5 JP 2020507342A5
- Authority
- JP
- Japan
- Prior art keywords
- target site
- homologous arm
- repair template
- homologous
- donor repair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762459203P | 2017-02-15 | 2017-02-15 | |
| US62/459,203 | 2017-02-15 | ||
| PCT/US2018/018370 WO2018152325A1 (en) | 2017-02-15 | 2018-02-15 | Donor repair templates multiplex genome editing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020507342A JP2020507342A (ja) | 2020-03-12 |
| JP2020507342A5 true JP2020507342A5 (https=) | 2022-10-17 |
| JP7236398B2 JP7236398B2 (ja) | 2023-03-09 |
Family
ID=63170730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019564394A Active JP7236398B2 (ja) | 2017-02-15 | 2018-02-15 | ドナー修復鋳型多重ゲノム編集 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11499149B2 (https=) |
| EP (2) | EP3583203B1 (https=) |
| JP (1) | JP7236398B2 (https=) |
| CN (1) | CN110446781A (https=) |
| AU (1) | AU2018221730B2 (https=) |
| CA (1) | CA3053499A1 (https=) |
| DK (1) | DK3583203T5 (https=) |
| ES (1) | ES2969213T3 (https=) |
| WO (1) | WO2018152325A1 (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015330699B2 (en) | 2014-10-10 | 2021-12-02 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| EP4464338A3 (en) | 2014-11-07 | 2025-02-12 | Editas Medicine, Inc. | Systems for improving crispr/cas-mediated genome-editing |
| EP3353296B1 (en) | 2015-09-24 | 2020-11-04 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
| US11597924B2 (en) | 2016-03-25 | 2023-03-07 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| US11236313B2 (en) | 2016-04-13 | 2022-02-01 | Editas Medicine, Inc. | Cas9 fusion molecules, gene editing systems, and methods of use thereof |
| US11293021B1 (en) | 2016-06-23 | 2022-04-05 | Inscripta, Inc. | Automated cell processing methods, modules, instruments, and systems |
| US9982279B1 (en) | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US10011849B1 (en) | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| JP2020530979A (ja) | 2017-06-30 | 2020-11-05 | インスクリプタ， インコーポレイテッド | 自動細胞処理方法、モジュール、機器及びシステム |
| US11866726B2 (en) | 2017-07-14 | 2024-01-09 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
| US12312383B2 (en) | 2018-04-18 | 2025-05-27 | Altius Institute For Biomedical Sciences | Animal pathogen-derived polypeptides and uses thereof for genetic engineering |
| US10557216B2 (en) | 2018-04-24 | 2020-02-11 | Inscripta, Inc. | Automated instrumentation for production of T-cell receptor peptide libraries |
| US10858761B2 (en) | 2018-04-24 | 2020-12-08 | Inscripta, Inc. | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells |
| US12264181B2 (en) | 2018-06-27 | 2025-04-01 | Altius Institute For Biomedical Sciences | Nucleic acid binding domains and methods of use thereof |
| CA3108767A1 (en) | 2018-06-30 | 2020-01-02 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| US11142740B2 (en) | 2018-08-14 | 2021-10-12 | Inscripta, Inc. | Detection of nuclease edited sequences in automated modules and instruments |
| SG11202103917VA (en) | 2018-10-16 | 2021-05-28 | Blueallele Llc | Methods for targeted insertion of dna in genes |
| US11214781B2 (en) | 2018-10-22 | 2022-01-04 | Inscripta, Inc. | Engineered enzyme |
| CN113840920A (zh) * | 2019-03-14 | 2021-12-24 | 加利福尼亚大学董事会 | 合并的敲入筛选和在内源基因座控制下共表达的异源多肽 |
| US11001831B2 (en) | 2019-03-25 | 2021-05-11 | Inscripta, Inc. | Simultaneous multiplex genome editing in yeast |
| AU2020247900A1 (en) | 2019-03-25 | 2021-11-04 | Inscripta, Inc. | Simultaneous multiplex genome editing in yeast |
| AU2020288623A1 (en) | 2019-06-06 | 2022-01-06 | Inscripta, Inc. | Curing for recursive nucleic acid-guided cell editing |
| CN110358792A (zh) * | 2019-07-19 | 2019-10-22 | 华中农业大学 | 外源基因定点整合至actb基因下游的打靶载体构建方法及其应用 |
| US11203762B2 (en) | 2019-11-19 | 2021-12-21 | Inscripta, Inc. | Methods for increasing observed editing in bacteria |
| AU2020407048A1 (en) | 2019-12-18 | 2022-06-09 | Inscripta, Inc. | Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells |
| US11225674B2 (en) | 2020-01-27 | 2022-01-18 | Inscripta, Inc. | Electroporation modules and instrumentation |
| US20210332388A1 (en) | 2020-04-24 | 2021-10-28 | Inscripta, Inc. | Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells |
| US11299731B1 (en) | 2020-09-15 | 2022-04-12 | Inscripta, Inc. | CRISPR editing to embed nucleic acid landing pads into genomes of live cells |
| US11512297B2 (en) | 2020-11-09 | 2022-11-29 | Inscripta, Inc. | Affinity tag for recombination protein recruitment |
| AU2021415461A1 (en) | 2021-01-04 | 2023-08-17 | Inscripta, Inc. | Mad nucleases |
| EP4274890A4 (en) | 2021-01-07 | 2024-11-27 | Inscripta, Inc. | MAD-NUCLEASES |
| US11884924B2 (en) | 2021-02-16 | 2024-01-30 | Inscripta, Inc. | Dual strand nucleic acid-guided nickase editing |
| JP2024543164A (ja) * | 2021-11-26 | 2024-11-19 | イミュネクサス・セラピューティクス・リミテッド | 細胞表面上の結合ドメイン分子 |
| EP4493706A4 (en) * | 2022-03-14 | 2026-03-18 | Univ California | INTEGRATION OF LARGE NUCLEIC ACIDS INTO GENOMES |
| CN116212022A (zh) * | 2022-12-19 | 2023-06-06 | 中国医学科学院医学生物学研究所 | 一种芳香烃受体基因AhR作为治疗靶点在制备抗HSV-1病毒药物中的应用 |
| CN118538425B (zh) * | 2024-06-06 | 2024-10-29 | 北京大学第一医院(北京大学第一临床医学院) | 一种vhl综合征肾癌的诊断模型及其应用 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US4873192A (en) | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
| GB8918616D0 (en) | 1989-08-15 | 1989-09-27 | Univ Glasgow | Herpes simplex virus type 1 mutant |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
| ES2061416T3 (es) | 1990-10-12 | 1997-03-01 | Max Planck Gesellschaft | Ribozimas modificadas. |
| US5652094A (en) | 1992-01-31 | 1997-07-29 | University Of Montreal | Nucleozymes |
| US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
| US5804413A (en) | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
| US5503022A (en) | 1993-01-25 | 1996-04-02 | Barone; Larry A. | Marine impeller tester |
| US5409813A (en) | 1993-09-30 | 1995-04-25 | Systemix, Inc. | Method for mammalian cell separation from a mixture of cell populations |
| GB9415319D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
| US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6187757B1 (en) | 1995-06-07 | 2001-02-13 | Ariad Pharmaceuticals, Inc. | Regulation of biological events using novel compounds |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| AU8605598A (en) | 1997-07-31 | 1999-02-22 | University Of Pittsburgh | Targeted hsv vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| FR2777909B1 (fr) | 1998-04-24 | 2002-08-02 | Pasteur Institut | Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex |
| US6692736B2 (en) | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| ATE318923T1 (de) | 2000-06-01 | 2006-03-15 | Univ North Carolina | Doppelsträngige parvovirus-vektoren |
| WO2002088346A2 (en) | 2001-05-01 | 2002-11-07 | National Research Council Of Canada | A system for inducible expression in eukaryotic cells |
| US8409861B2 (en) | 2003-08-08 | 2013-04-02 | Sangamo Biosciences, Inc. | Targeted deletion of cellular DNA sequences |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| FR2872170B1 (fr) | 2004-06-25 | 2006-11-10 | Centre Nat Rech Scient Cnrse | Lentivirus non interactif et non replicatif, preparation et utilisations |
| JP5136766B2 (ja) | 2004-12-15 | 2013-02-06 | ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | キメラベクター |
| EP2027262B1 (en) | 2006-05-25 | 2010-03-31 | Sangamo Biosciences Inc. | Variant foki cleavage half-domains |
| US20110239315A1 (en) | 2009-01-12 | 2011-09-29 | Ulla Bonas | Modular dna-binding domains and methods of use |
| WO2010093784A2 (en) | 2009-02-11 | 2010-08-19 | The University Of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| EP2449135B1 (en) | 2009-06-30 | 2016-01-06 | Sangamo BioSciences, Inc. | Rapid screening of biologically active nucleases and isolation of nuclease-modified cells |
| EP2524037B1 (en) | 2010-01-12 | 2018-05-16 | The University Of North Carolina At Chapel Hill | Restrictive inverted terminal repeats for viral vectors |
| US9169492B2 (en) | 2010-02-05 | 2015-10-27 | The University Of North Carolina At Chapel Hill | Compositions and methods for enhanced parvovirus transduction |
| ES2751916T3 (es) | 2010-02-08 | 2020-04-02 | Sangamo Therapeutics Inc | Semidominios de escisión genomanipulados |
| US8450107B1 (en) | 2011-11-30 | 2013-05-28 | The Broad Institute Inc. | Nucleotide-specific recognition sequences for designer TAL effectors |
| US20150017136A1 (en) * | 2013-07-15 | 2015-01-15 | Cellectis | Methods for engineering allogeneic and highly active t cell for immunotherapy |
| BR112014029417B1 (pt) * | 2012-05-25 | 2023-03-07 | Cellectis | Método ex vivo para a preparação de células t para imunoterapia |
| CN104781789B (zh) | 2012-12-20 | 2018-06-05 | 三菱电机株式会社 | 车载装置 |
| EP3925618A1 (en) | 2013-07-29 | 2021-12-22 | 2seventy bio, Inc. | Multipartite signaling proteins and uses thereof |
| US9108442B2 (en) | 2013-08-20 | 2015-08-18 | Ricoh Company, Ltd. | Image forming apparatus |
| BR112016024945A2 (pt) | 2014-04-28 | 2017-10-24 | Recombinetics Inc | edição de gene multiplex em suínos |
| KR102531016B1 (ko) | 2014-11-21 | 2023-05-10 | 리제너론 파마슈티칼스 인코포레이티드 | 쌍 형성된 가이드 rna를 사용하는 표적화된 유전자 변형을 위한 방법 및 조성물 |
| KR102888521B1 (ko) * | 2015-04-06 | 2025-11-19 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna |
| EP3289080B1 (en) * | 2015-04-30 | 2021-08-25 | The Trustees of Columbia University in the City of New York | Gene therapy for autosomal dominant diseases |
| GB2531454A (en) | 2016-01-10 | 2016-04-20 | Snipr Technologies Ltd | Recombinogenic nucleic acid strands in situ |
| JP2019509738A (ja) | 2016-03-11 | 2019-04-11 | ブルーバード バイオ， インコーポレイテッド | ゲノム編集された免疫エフェクター細胞 |
| US20190161530A1 (en) | 2016-04-07 | 2019-05-30 | Bluebird Bio, Inc. | Chimeric antigen receptor t cell compositions |
| AU2017312132A1 (en) | 2016-08-19 | 2019-03-21 | Bluebird Bio, Inc. | Genome editing enhancers |
| KR102451510B1 (ko) | 2016-09-08 | 2022-10-07 | 2세븐티 바이오, 인코포레이티드 | Pd-1 호밍 엔도뉴클레아제 변이체, 조성물 및 사용 방법 |
-
2018
- 2018-02-15 EP EP18755081.9A patent/EP3583203B1/en active Active
- 2018-02-15 CA CA3053499A patent/CA3053499A1/en active Pending
- 2018-02-15 EP EP23205250.6A patent/EP4317447A3/en active Pending
- 2018-02-15 AU AU2018221730A patent/AU2018221730B2/en active Active
- 2018-02-15 US US16/485,345 patent/US11499149B2/en active Active
- 2018-02-15 JP JP2019564394A patent/JP7236398B2/ja active Active
- 2018-02-15 CN CN201880020639.2A patent/CN110446781A/zh active Pending
- 2018-02-15 DK DK18755081.9T patent/DK3583203T5/da active
- 2018-02-15 ES ES18755081T patent/ES2969213T3/es active Active
- 2018-02-15 WO PCT/US2018/018370 patent/WO2018152325A1/en not_active Ceased
-
2022
- 2022-10-21 US US18/048,631 patent/US12559742B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020507342A5 (https=) | ||
| US12365922B2 (en) | Allele editing and applications thereof | |
| Georgiadis et al. | Base-edited CAR T cells for combinational therapy against T cell malignancies | |
| Hartweger et al. | HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells | |
| Miliotou et al. | CAR T-cell therapy: a new era in cancer immunotherapy | |
| EP3535392B1 (en) | Immunologically discernible cell surface variants for use in cell therapy | |
| JP6668340B2 (ja) | 新規ｃｈｏ組込み部位およびその使用 | |
| JP7471289B2 (ja) | 抗ｌｉｖ１免疫細胞癌療法 | |
| US20250074965A1 (en) | Anti-ptk7 immune cell cancer therapy | |
| JP7422365B2 (ja) | 外来抗原レセプター遺伝子導入細胞の製造方法 | |
| JP2019509738A5 (https=) | ||
| JP2022508942A5 (https=) | ||
| JP2019525771A5 (https=) | ||
| RU2018107802A (ru) | Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин | |
| JP2017086084A5 (https=) | ||
| JP2018522072A5 (https=) | ||
| Zhang et al. | Synthetic biology in chimeric antigen receptor T (CAR T) cell engineering | |
| KR20140077219A (ko) | 유전자 변형된 ｔ 세포 수용체 마우스 | |
| RU2017136072A (ru) | Триспецифические связывающие молекулы для лечения вирусной инфекции гепатита в и связанных состояний | |
| TW201803981A (zh) | 用於以使用增強表現基因座爲基礎製造抗體之組成物及方法 | |
| Maetzig et al. | All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinase | |
| Thöne et al. | CRISPR/Cas9-mediated generic protein tagging in mammalian cells | |
| JP2020535832A (ja) | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 | |
| US20190297861A1 (en) | Animals, cells, ligands, polypeptides & methods | |
| US20230133564A1 (en) | Cd3-fusion protein and uses thereof |